NYSE, NYSE · Common Stock · Pharmaceutical Preparations
American pharmaceutical company
222 entities across 47 jurisdictions, 6 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-11 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| BC ULC | Canada | |
| seventy bio, Inc | United States | |
| seventy bio Securities Corporation | United States | |
| Park LLC | United States | |
| Canada Inc. | Canada | |
| Abraxis BioScience Australia Pty Ltd. | Australia | |
| Abraxis BioScience International Holding Company, Inc. | United States | |
| Abraxis BioScience, Inc. | United States | |
| Abraxis BioScience, LLC | United States | |
| AbVitro LLC | United States | |
| Adnexus, a Bristol-Myers Squibb R&D Company | United States | |
| AHI Investment, LLC | United States | |
| Allard Labs Acquisition G.P. | United States | |
| Amira Pharmaceuticals, Inc. | United States | |
| Apothecon LLC | United States | |
| Blisa Acquisition G.P. | United States | |
| BMS Bermuda Nominees L.L.C. | United States | |
| BMS Forex Company | United States | |
| BMS Holdings Netherlands Beta B.V. | Netherlands | |
| BMS Ireland Capital Funding Designated Activity Company | Ireland | |
| BMS Korea Holdings L.L.C. | United States | |
| BMS Latin American Nominees L.L.C. | United States | |
| BMS Netherlands Operations B.V. | Netherlands | |
| BMS Pharmaceuticals Germany Holdings B.V. | Netherlands | |
| BMS Pharmaceuticals International Holdings Netherlands B.V. | Netherlands | |
| BMS Pharmaceuticals Korea Holdings B.V. | Netherlands | |
| BMS Pharmaceuticals Mexico Holdings B.V. | Netherlands | |
| BMS Pharmaceuticals Netherlands Holdings B.V. | Netherlands | |
| BMS Real Estate LLC | United States | |
| BMS Spain Investments LLC | United States | |
| BMS Strategic Portfolio Investments Holdings, Inc. | United States | |
| Bristol Laboratories International, S.A. | United States | |
| Bristol Laboratories Medical Information Systems Inc. | United States | |
| Bristol-Myers (Andes) L.L.C. | United States | |
| Bristol-Myers Squibb (Beijing) Innovation Pharmaceutical Technology Co., Ltd. | China | |
| Bristol-Myers Overseas Corporation | United States | |
| Bristol-Myers Squibb (China) Investment Co., Ltd. | China | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co., Ltd. | China | |
| Bristol-Myers Squibb (Israel) Ltd. | Israel | |
| Bristol-Myers Squibb (NZ) Limited | New Zealand | |
| Bristol-Myers Squibb (Proprietary) Limited | South Africa | |
| Bristol-Myers Squibb (Shanghai) Trading Co. Ltd. | China | |
| Bristol-Myers Squibb (Singapore) Pte. Limited | Singapore | |
| Bristol-Myers Squibb (West Indies) Ltd. | United States | |
| Bristol-Myers Squibb A.E. | Greece | |
| Bristol-Myers Squibb Aktiebolag | Sweden | |
| Bristol-Myers Squibb Argentina S. R. L. | Argentina | |
| Bristol-Myers Squibb Australia Pty. Ltd. | Australia | |
| Bristol-Myers Squibb B.V. | Netherlands | |
| Bristol-Myers Squibb Belgium S.A. | Belgium | |
| Bristol-Myers Squibb Business Services India Private Limited | India | |
| Bristol-Myers Squibb Business Services Limited | United Kingdom | |
| Bristol-Myers Squibb Canada Co. | Canada | |
| Bristol-Myers Squibb Canada International Limited | Canada | |
| Bristol-Myers Squibb de Colombia S.A. | Colombia | |
| Bristol-Myers Squibb de Mexico, S. de R.L. de C.V. | Mexico | |
| Bristol-Myers Squibb Delta Company Limited | Ireland | |
| Bristol-Myers Squibb Denmark Filial of Bristol-Myers Squibb AB | Denmark | |
| Bristol-Myers Squibb Egypt, LLC | Egypt | |
| Bristol-Myers Squibb EMEA Sarl | France | |
| Bristol-Myers Squibb Epsilon Holdings Unlimited Company | Ireland | |
| Bristol-Myers Squibb Farmaceutica Ltda. | Brazil | |
| Bristol-Myers Squibb Farmaceutica Portuguesa S.A. | Portugal | |
| Bristol-Myers Squibb Ges mbH. | Austria | |
| Bristol-Myers Squibb GmbH & Co. KGaA | Germany | |
| Bristol-Myers Squibb Hanbai K.K | Japan | |
| Bristol-Myers Squibb Holding Germany GmbH & Co. KG | Germany | |
| Bristol-Myers Squibb Holdings 2002 Limited | United Kingdom | |
| Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH | Germany | |
| Bristol-Myers Squibb Holdings Ireland Unlimited Company | Ireland | |
| Bristol-Myers Squibb Holdings Limited | United Kingdom | |
| Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company | Switzerland | |
| Bristol-Myers Squibb Ilaclari, Inc. | United States | |
| Bristol-Myers Squibb India Pvt. Limited | India | |
| Bristol-Myers Squibb International Company Unlimited Company | Ireland | |
| Bristol-Myers Squibb International Corporation | United States | |
| Bristol-Myers Squibb Investco, L.L.C. | United States | |
| Bristol-Myers Squibb K.K. | Japan | |
| Bristol-Myers Squibb Kft. | Hungary | |
| Bristol-Myers Squibb Manufacturing Company Unlimited Company | Ireland | |
| Bristol-Myers Squibb Marketing Services S.R.L. | Romania | |
| Bristol-Myers Squibb MEA GmbH | Switzerland | |
| Bristol-Myers Squibb Middle East & Africa FZ-LLC | United Arab Emirates | |
| Bristol-Myers Squibb Norway Holdings Inc. | United States | |
| Bristol-Myers Squibb Norway AS | Norway | |
| Bristol-Myers Squibb Peru S.A. | Peru | |
| Bristol-Myers Squibb Pharma (HK) Ltd | Hong Kong | |
| Bristol-Myers Squibb Pharma (Thailand) Limited | Thailand | |
| Bristol-Myers Squibb Pharma Company | United States | |
| Bristol-Myers Squibb Pharma EEIG | Ireland | |
| Bristol-Myers Squibb Pharma Holding Company, LLC | United States | |
| Bristol-Myers Squibb Pharma Ventures Corporation | United States | |
| Bristol-Myers Squibb Pharmaceuticals Limited | United Kingdom | |
| Bristol-Myers Squibb Pharmaceuticals Unlimited Company | Ireland | |
| Bristol-Myers Squibb Polska Sp. z o.o. | Poland | |
| Bristol-Myers Squibb Products S.A. | Switzerland | |
| Bristol-Myers Squibb Puerto Rico, Inc. | United States | |
| Bristol Myers Squibb Regional Headquarter Company | Saudi Arabia | |
| Bristol-Myers Squibb Romania S.R.L. | Romania | |
| Bristol-Myers Squibb S.r.l. | Italy | |
| Bristol-Myers Squibb SA | Switzerland | |
| Bristol-Myers Squibb SAS | France | |
| Bristol-Myers Squibb Service Ltd. | Bermuda | offshore centre |
| Bristol-Myers Squibb Services Sp. z o.o. | Poland | |
| Bristol-Myers Squibb Services Unlimited Company | Ireland | |
| Bristol-Myers Squibb Spol. s r.o. | Czech Republic | |
| Bristol-Myers Squibb TGF Beta Inc. | Canada | |
| Bristol-Myers Squibb Trustees Ltd. | United Kingdom | |
| Bristol-Myers Squibb Verwaltungs GmbH | Germany | |
| Bristol-Myers Squibb, S.A.U. | Spain | |
| Bristol-Myers Squibb/Astrazeneca EEIG | United Kingdom | |
| Bristol-Myers Squibb/Pfizer EEIG | Ireland | |
| Cardioxyl Pharmaceuticals, LLC | United States | |
| Celgene CAR LLC | United States | |
| Celgene Chemicals Sarl | Switzerland | |
| Celgene China Holdings LLC | United States | |
| Celgene Corporation | United States | |
| Celgene Distribution B.V. | Netherlands | |
| Celgene Europe B.V. | Netherlands | |
| Celgene Europe Limited | United Kingdom | |
| Celgene Financing Company, LLC | United States | |
| Celgene Global Holdings Sarl | Switzerland | |
| Celgene Holdings East Corporation | United States | |
| Celgene International Holdings Corporation | United States | |
| Celgene International II Sàrl | Switzerland | |
| Celgene International Inc. | United States | |
| Celgene International Sàrl | Switzerland | |
| Celgene Kappa Holdings LLC | United States | |
| Celgene Limited | Hong Kong | |
| Celgene Logistics Sarl | Switzerland | |
| Celgene Logistics Sarl (Sucursale Mexico) | Mexico | |
| Celgene Netherlands BV | Netherlands | |
| Celgene Netherlands Investment BV | Netherlands | |
| Celgene NJ Investment Co | United States | |
| Celgene Omicron Holdings, Inc. | United States | |
| Celgene Pharmaceutical (Shanghai) Company Limited | China | |
| Celgene Pty Limited | Australia | |
| Celgene Puerto Rico Distribution LLC | Puerto Rico | |
| Celgene Quanticel Research, Inc. | United States | |
| Celgene R&D Sarl | Switzerland | |
| Celgene Receptos Limited | United Kingdom | |
| Celgene Receptos Sàrl | Switzerland | |
| Celgene Research and Development I ULC | Canada | |
| Celgene Research and Investment Company II, LLC | United States | |
| Celgene Research Incubator At Summit West, LLC | United States | |
| Celgene Research SL | Spain | |
| Celgene RIVOT Beta Holdings LLC | United States | |
| Celgene RIVOT SRL | Barbados | offshore centre |
| Celgene Sàrl AU | Morocco | |
| Celgene Sdn Bhd | Malaysia | |
| Celgene Summit Investment Co | United States | |
| Celgene Switzerland Holdings Sarl | Switzerland | |
| Celgene Switzerland LLC | United States | |
| Celgene UK Distribution Limited | United Kingdom | |
| Celgene UK Holdings Limited | United Kingdom | |
| Celgene UK Manufacturing (II) Limited | United Kingdom | |
| Celgene UK Manufacturing (III) Limited | United Kingdom | |
| Celgene UK Manufacturing Limited | United Kingdom | |
| Celgene, S. de R.L. de C.V. | Mexico | |
| Celmed Ltd. | Bermuda | offshore centre |
| CHT I, LLC | United States | |
| CHT II, LLC | United States | |
| CHT III, LLC | United States | |
| CHT IV, LLC | United States | |
| Circ Bio, Inc. | United States | |
| Cormorant Pharmaceuticals AB | Sweden | |
| Delinia, LLC | United States | |
| Deuteria Pharmaceuticals, Inc. | United States | |
| E. R. Squibb & Sons Inter-American Corporation | United States | |
| E. R. Squibb & Sons Limited | United Kingdom | |
| E. R. Squibb & Sons, L.L.C. | United States | |
| FermaVir Pharmaceuticals, L.L.C. | United States | |
| FermaVir Research, L.L.C. | United States | |
| Flexus Biosciences, Inc. | United States | |
| Forbius PTY Limited | Australia | |
| Foxtrot Acquisition Sub ULC | Canada | |
| GenPharm International, L.L.C. | United States | |
| Gloucester Pharmaceuticals, LLC | United States | |
| Grove Insurance Company Ltd. | Bermuda | offshore centre |
| Impact Biomedicines, Inc. | United States | |
| Inhibitex, L.L.C. | United States | |
| Innate Tumor Immunity, Inc. | United States | |
| iPierian, Inc. | United States | |
| JuMP Holdings, LLC | United States | |
| Juno Therapeutics, Inc. | United States | |
| Karuna Securities Corporation | United States | |
| Karuna Therapeutics, Inc. | United States | |
| Linson Investments Limited | Cayman Islands | offshore centre |
| Mead Johnson Jamaica Ltd. | United States | |
| Mirati Therapeutics (Suisse) GmbH | Switzerland | |
| Mirati Therapeutics B.V. | Netherlands | |
| Mirati Therapeutics, Inc. | United States | |
| Morris Avenue Investment II, LLC | United States | |
| Morris Avenue Investment LLC | United States | |
| MyoKardia Australia Pty Ltd | Australia | |
| MyoKardia, Inc. | United States | |
| Orbital Therapeutics, Inc. | United States | |
| Orbital Therapeutics Security Corporation | United States | |
| Oy Bristol-Myers Squibb (Finland) AB | Finland | |
| Padlock Therapeutics, Inc. | United States | |
| Pharmion LLC | United States | |
| Princeton Pharmaceutical Products, Inc. | United States | |
| RayzeBio Pharmaceuticals (Chengdu) Co., Ltd. | China | |
| RayzeBio, Inc. | United States | |
| Receptos Holdings LLC | United States | |
| Receptos LLC | United States | |
| Receptos Services LLC | United States | |
| RedoxTherapies, Inc. | United States | |
| Signal Pharmaceuticals, LLC | United States | |
| Sino-American Shanghai Squibb Pharmaceuticals Limited | China | |
| SPV A Holdings ULC | Canada | |
| Squibb Middle East S.A. | Panama | offshore centre |
| Summit West Celgene LLC | United States | |
| Swords Laboratories Unlimited Company | Ireland | |
| Turning Point Therapeutics, Inc. | United States | |
| VentiRx Pharmaceuticals Inc. | United States | |
| Westwood-Intrafin SA | Switzerland | |
| Westwood-Squibb Pharmaceuticals, Inc. | United States | |
| X-Body, Inc. | United States | |
| ZymoGenetics Paymaster, LLC | United States | |
| ZymoGenetics, Inc. | United States | |
| ZymoGenetics, LLC | United States |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $42.5B | −$9.0B | $13.3B | 72.3% | 2,258,000,000 |
| FY2021 | $46.4B | $7.0B | $15.2B | — | 2,245,000,000 |
| FY2022 | $46.2B | $6.3B | $11.9B | — | 2,146,000,000 |
| FY2023 | $45.0B | $8.0B | $12.7B | — | 2,078,000,000 |
| FY2024 | $48.3B | −$8.9B | $13.9B | — | 2,027,000,000 |
| FY2025 | $48.2B | $7.1B | $12.8B | — | 2,039,000,000 |
14 institutions tracked — 8 added, 5 reduced, 1 opened a new position, 2 sold out.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 31,707,643 | +21,457,405 | $1.8B |
| JPMORGAN CHASE & CO | Active fund | 74,817,565 | −21,353,652 | $4.4B |
| BlackRock, Inc. | Index | 180,384,994 | +8,702,106 | $10.4B |
| FMR LLC | Active fund | 16,293,303 | +5,622,200 | $938.8M |
| STATE STREET CORP | Index | 102,408,940 | +3,844,026 | $5.9B |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 27,357,486 | −2,273,619 | $1.6B |
| CITADEL ADVISORS LLC | Hedge fund | 7,686,029 | −1,844,105 | $442.9M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 3,914,086 | −1,592,910 | $225.5M |
| BANK OF AMERICA CORP /DE/ | Active fund | 34,095,619 | +1,458,354 | $2.0B |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 56,443,077 | +1,156,903 | $3.2B |
| Point72 Asset Management, L.P. | Hedge fund | 1,359,600 | +259,102 | $78.3M |
| MORGAN STANLEY | Active fund | 29,009,144 | −189,529 | $1.7B |
| Capital World Investors | Active fund | 2,244,242 | +19,212 | $129.3M |
NORGES BANK holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
BRISTOL MYERS SQUIBB CO files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.